Literature DB >> 18721668

Synergistic anti-hyperalgesia of electroacupuncture and low dose of celecoxib in monoarthritic rats: involvement of the cyclooxygenase activity in the spinal cord.

Wen-Li Mi1, Qi-Liang Mao-Ying, Qiong Liu, Xiao-Wei Wang, Yan-Qing Wang, Gen-Cheng Wu.   

Abstract

Electroacupuncture (EA) can effectively control the exaggerated pain in humans with inflammatory disease and animals with experimental inflammatory pain. However, there have been few investigations on the effect of co-administration of EA and analgesics and the underlying synergistic mechanism. Using behavioral test, RT-PCR analysis, enzyme immunoassay (EIA) and enzyme-linked immunosorbent assay (ELISA), the present study demonstrated that (1) Unilateral intra-articular injection of complete Freund's adjuvant (CFA) produced a constant hyperalgesia and an up-regulation of the prostaglandin E(2) (PGE(2)) level as well as the tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6 levels in the spinal cord; (2) Celecoxib, a selective inhibitor of cyclooxygenase-2 (COX-2), at a dose of 2, 10, and 20 mg/kg (twice daily, p.o.), presented a dose-dependent anti-hyperalgesic effect; (3) Repeated EA stimulation of ipsilateral 'Huan-Tiao' (GB30) and 'Yang-Ling-Quan' (GB34) acupoints significantly suppressed CFA-induced hyperalgesia, and markedly inhibited the CFA-induced increase of the level of PGE(2) as well as IL-1beta, IL-6, and TNF-alpha in the spinal cord; (4) EA combined with low dose of celecoxib (2 mg/kg, twice daily, p.o.) greatly enhanced the anti-hyperalgesic effects of EA, with a synergistic reversing effect on CFA-induced up-regulation of spinal PGE(2), but not on the IL-1beta, IL-6, or TNF-alpha. These data indicated that repeated EA combined with low dose of celecoxib produced synergistic anti-hyperalgesic effect in the CFA-induced monoarthritic rats, which could be made possible by regulating the activity of spinal COX, hence the spinal PGE(2) level. Thus, this combination may provide an effective strategy for pain management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721668     DOI: 10.1016/j.brainresbull.2008.04.008

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

Review 1.  Mechanisms of acupuncture-electroacupuncture on persistent pain.

Authors:  Ruixin Zhang; Lixing Lao; Ke Ren; Brian M Berman
Journal:  Anesthesiology       Date:  2014-02       Impact factor: 7.892

2.  Antioxidant and angiostatic effect of Spirulina platensis suspension in complete Freund's adjuvant-induced arthritis in rats.

Authors:  Eman A I Ali; Bassant M Barakat; Ranya Hassan
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

3.  Inhibition of Spinal Interlukin-33/ST2 Signaling and Downstream ERK and JNK Pathways in Electroacupuncture Analgesia in Formalin Mice.

Authors:  Ping Han; Shenbin Liu; Mengting Zhang; Jing Zhao; Yanqing Wang; Gencheng Wu; Wenli Mi
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

4.  Effect of Electroacupuncture Intervention on Expression of CGRP, SP, COX-1, and PGE2 of Dorsal Portion of the Cervical Spinal Cord in Rats with Neck-Incision Pain.

Authors:  Li-Na Qiao; Jun-Ying Wang; Yong-Sheng Yang; Shu-Ping Chen; Yong-Hui Gao; Jian-Liang Zhang; Jun-Ling Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-02       Impact factor: 2.629

5.  Electroacupuncture Alleviates Experimental Chronic Inflammatory Pain by Inhibiting Calcium Voltage-Gated Channel-Mediated Inflammation.

Authors:  Jie Zhou; Ying Jin; Ruijie Ma; Hongyun Song; Qin Chen; Yueyang Chai; Yi Liang; You Zhou; Jianqiao Fang
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-10       Impact factor: 2.629

6.  Melastoma malabathricum Linn attenuates complete freund's adjuvant-induced chronic inflammation in Wistar rats via inflammation response.

Authors:  Vikas Kumar; Prakash Chandra Bhatt; Mahfoozur Rahman; Dinesh Kumar Patel; Nikunj Sethi; Atul Kumar; Nikhil Kumar Sachan; Gaurav Kaithwas; F A Al-Abbasi; Firoz Anwar; Amita Verma
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 4.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.